| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066438A1 Rylene derivatives and their use as dyes |
| 08/29/2002 | WO2002066416A1 Method of synthesizing camptothecin-relating compounds |
| 08/29/2002 | WO2002048109A3 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
| 08/29/2002 | WO2002016369A3 Novel macrocycles and uses thereof |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/29/2002 | US20020120152 Aminoaryl oxazolidinone N-oxides |
| 08/29/2002 | US20020120142 Method for making 8-hydroxyjulolidine compound |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | DE10108156A1 Rylenderivate Rylene derivatives |
| 08/29/2002 | CA2683768A1 Method of synthesizing camptothecin-relating compounds |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 08/28/2002 | EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists |
| 08/28/2002 | CN1089757C Process for producing aminonitropyridines |
| 08/27/2002 | US6441197 4-amino-5-(n-methylamino)-2',7'-difluoro-3',6'-dihydroxy-spiro (isobenzofuran-1,9'-xanthen)-3-one; direct, accurate, highly sensitive intracellular fluorescent measurement of nitrogen monoxide; nondamaging to tissues and cells; light stable |
| 08/27/2002 | US6441188 Aminoaryl oxazolidinone N-oxides |
| 08/27/2002 | US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/27/2002 | US6441174 Process for preparing bis(hydroxymethyl)perylenetetracarboximide |
| 08/27/2002 | US6441172 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 08/27/2002 | US6441167 Cinoxacin lanthanide chelates and their use as biomolecular probes |
| 08/27/2002 | US6440975 Amino acid derivatives, the preparation and use thereof as endothelin antagonists |
| 08/27/2002 | US6440960 An oxygen or sulfure or sulfure oxide or dioxide containing tricyclic compouund useful for treating the disorder manifesting hypersecretion of corticotropin releasing factor |
| 08/27/2002 | US6440586 Suspended in a polymer such as polyvinylcarbazole |
| 08/22/2002 | WO2002064598A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064597A2 Method for purifying 20(s)-camptothecin |
| 08/22/2002 | WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |
| 08/22/2002 | US20020115862 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115854 Thrombin or factor Xa inhibitors |
| 08/22/2002 | US20020115663 Novel compounds |
| 08/22/2002 | US20020115595 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/22/2002 | DE10107243A1 Benzodioxinopyrrole, deren Herstellung und Verwendung Benzodioxinopyrrole, their preparation and use |
| 08/22/2002 | CA2433778A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2405532A1 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/21/2002 | EP1232160A1 Spiro(2h-1-benzopyran-2,4'-piperidine)derivates as glycine transport inhibitors |
| 08/21/2002 | CN1089341C Pyridonecarboxylic acid derivatives and intermediates for synthesis and use thereof |
| 08/20/2002 | US6436941 Treating schizophrenia, depression, and parkinson's disease; side effect reduction |
| 08/20/2002 | CA2077695C Hydropyridine derivatives having antithrombotic activity |
| 08/15/2002 | WO2002062802A1 Coumarin derivative, process for producing the same, and luminescent agent and luminescent element each containing the same |
| 08/15/2002 | WO2002062791A1 Hetaryl substituted homotetramic and homotetronic acids and the use thereof as pesticides |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062767A1 Novel quinazoline derivatives |
| 08/15/2002 | WO2002062340A1 Highly lipophilic camptothecin prodrugs, methods of preparation, and formulations thereof |
| 08/15/2002 | US20020111489 Combining an aqueous base and 20(S)-camptothecin to convert the lactone ring into a carboxylate salt, hydrogenation in the presnce of a transition metal catalyst, acidifying to form crystals, adding a polar aprotic solvent, and separating |
| 08/15/2002 | US20020111358 Phenoxypropylamine compounds |
| 08/15/2002 | US20020111294 Administering an organocobalt complex |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230225A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 08/14/2002 | EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor |
| 08/14/2002 | EP1071455A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0703916B1 14-substituted marcfortines and derivatives useful as antiparasitic agents |
| 08/13/2002 | US6433177 Reacting n-carboxyanhydride and butylamine |
| 08/13/2002 | US6433176 Method for making 8-hydroxyjulolidine compound |
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6432955 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | CA2216633C Synthesis of bis-indolylmaleimides |
| 08/08/2002 | WO2002060904A2 A process for the preparation of epothilone analogs |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060876A1 Triaryl compounds and utilization thereof |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002030455A3 Agents for the treatment of viral infections |
| 08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | US20020107402 Aminoaryl oxazolidinone N-oxides |
| 08/08/2002 | US20020107398 Microbicides in crop protection |
| 08/08/2002 | US20020107397 Provide polymeric resin products having low polydispersity. |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228045A2 Heterocyclic cytotoxic agents |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 08/06/2002 | CA2231812C Cyclic nitrones and pharmaceutical compositions containing them |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002058701A1 Pharmaceutical dosage forms of epothilones for oral administration |
| 08/01/2002 | WO2002058700A1 Methods of administering epothilone analogs for the treatment of cancer |
| 08/01/2002 | WO2002058699A1 Pharmaceutical forms of epothilones for oral administration |
| 08/01/2002 | US20020103259 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | CA2434584A1 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones |
| 07/31/2002 | EP1227099A1 Fused Pyrazolyl compounds |
| 07/31/2002 | EP1227097A1 Ucs1025 derivatives |
| 07/31/2002 | EP1226145A1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them |